Suppr超能文献

TNM 分期为 I 期的结直肠癌复发的危险因素。

Risk factors of recurrence in TNM stage I colorectal cancer.

作者信息

Paik Jin-Hee, Ryu Chun-Geun, Hwang Dae-Yong

机构信息

Department of Surgery, Colorectal Cancer Center, Konkuk University Medical Center, Seoul, Korea.

Department of Surgery, Konkuk University School of Medicine, Seoul, Korea.

出版信息

Ann Surg Treat Res. 2023 May;104(5):281-287. doi: 10.4174/astr.2023.104.5.281. Epub 2023 Apr 28.

Abstract

PURPOSE

TNM stage I colorectal cancer (CRC) can recur, although the recurrence rate is low. Few studies have evaluated the risk factors for TNM stage I CRC recurrence. This study aimed to evaluate the TNM stage I CRC recurrence rate, as well as risk factors for recurrence.

METHODS

In this retrospective study, we reviewed the database of patients who had undergone surgery for TNM stage I CRC between November 2008 and December 2014 without receiving neoadjuvant therapy or transanal excision for rectal cancer. Our analysis included 173 patients. Primary lesions were found in the colon of 133 patients and in the rectum of 40 patients.

RESULTS

The CRC recurrence rate was 2.9% (5 out of 173 patients). For colon cancer patients, tumor size was not associated with higher recurrence risk (P = 0.098). However, for rectal cancer patients, both tumor size (≥3 cm) and T stage were associated with higher recurrence risk (P = 0.046 and P = 0.046, respectively). Of the 5 recurrent cases, 1 patient exhibited disease progression despite treatment, 1 patient maintained stable disease status after recurrence treatment, and 3 patients had no evidence of a tumor after recurrence treatment.

CONCLUSION

Our findings suggest that tumor size and T stage are predictors of stage I rectal cancer recurrence, and careful monitoring and follow-up of patients with larger tumors may be warranted.

摘要

目的

TNM 分期为 I 期的结直肠癌(CRC)虽复发率低,但仍会复发。很少有研究评估 TNM 分期为 I 期 CRC 复发的危险因素。本研究旨在评估 TNM 分期为 I 期 CRC 的复发率及复发危险因素。

方法

在这项回顾性研究中,我们查阅了 2008 年 11 月至 2014 年 12 月期间接受 TNM 分期为 I 期 CRC 手术且未接受新辅助治疗或直肠癌经肛门切除术的患者数据库。我们的分析纳入了 173 例患者。133 例患者的原发灶位于结肠,40 例患者的原发灶位于直肠。

结果

CRC 复发率为 2.9%(173 例患者中有 5 例)。对于结肠癌患者,肿瘤大小与较高的复发风险无关(P = 0.098)。然而,对于直肠癌患者,肿瘤大小(≥3 cm)和 T 分期均与较高的复发风险相关(分别为 P = 0.046 和 P = 0.046)。在 5 例复发病例中,1 例患者尽管接受了治疗仍出现疾病进展,1 例患者复发治疗后疾病状态保持稳定,3 例患者复发治疗后无肿瘤证据。

结论

我们的研究结果表明,肿瘤大小和 T 分期是 I 期直肠癌复发的预测因素,对于肿瘤较大的患者可能需要进行仔细的监测和随访。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验